Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors--ready for prime time?
- PMID: 23630170
- DOI: 10.1002/pbc.24548
Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors--ready for prime time?
Comment on
-
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.Pediatr Blood Cancer. 2013 Aug;60(8):1375-81. doi: 10.1002/pbc.24505. Epub 2013 Feb 25. Pediatr Blood Cancer. 2013. PMID: 23441093 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources